Companies: 10,795·Total market cap: $144.5T

RedHill Biopharma Ltd.

RedHill Biopharma Ltd.

RDHLNASDAQHealthcare● Active

$1.02

$-0.01(-0.97%)

Market Cap$3205714

P/E Ratio—

52W High$3.31

52W Low$0.71

Avg Volume61K

Open$1.03

Beta4.97

股票排行：Drug Manufacturers - Specialty & Generic·Healthcare·查看全部市值排行 →

RedHill Biopharma Ltd.（RDHL）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · RDHL · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-4.00Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$9.5MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding3.2MShares outstanding history

Next EarningsAug 13, 2026Est.Earnings history

探索 RedHill Biopharma Ltd. 数据

分析师预测$— · Buy

股息不分红

营收$286000-96.44%

盈利EPS $0.00+100.00%

财务快照

FY 2025Revenue$286000.00▼ 96.44% YoY

202320242025

FY 2025Net Income-$429000.00▲ +94.81% YoY

202320242025

FY 2025EPS$0.00▲ +100.00% YoY

202320242025

TTM:Revenue: $9.5MNet Income: -$9.3MEPS: $-4.00View income statement →

分析师评级与目标价

Buy10 位分析师

Strong Buy

0

Buy

10

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$—Low

$1.02Current

$—Avg Target

$—High

合计: 10 · 买入占比: 100.0%

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

RedHill Biopharma Ltd.

$1.02-0.97%$3.2M #2

$14.65-6.27%$474,162 #3

Bio Green Med Solution, Inc.

$1.10-26.67%$2.4M #4

$0.54-0.18%$697,335 #5

CNS Pharmaceuticals, Inc.

$4.89-2.20%$2.8M #6

Flora Growth Corp.

$7.79-32.14%$4.2M

股票表现

1D-0.97%

1W+3.03%

1M+0.99%

3M+10.38%

YTD-0.97%

1Y-50.24%

5Y-99.99%

关于 RedHill Biopharma Ltd.

CEODror Ben-Asher

IPO DateJan 7, 2013

Employees35

CountryIL

Websiteredhillbio.com

RedHill Biopharma Ltd. is a specialized pharmaceutical firm concentrating its efforts mainly on therapies for digestive tract conditions and various infections. The company markets several gastrointes…

Drug Manufacturers - Specialty & Generic HealthcareNASDAQADRIL

关于股票概览与关键数据

RedHill Biopharma Ltd.（RDHL）是 Drug Manufacturers - Specialty & Generic 行业的 Healthcare 类公司，于 Jan 7, 2013 在 NASDAQ 上市。截至最近交易日，RDHL 股价为 $1.02，市值约为 $3.2M。过去12个月累计回报 -50.24%，年初至今回报 -0.97%。

根据 10 位华尔街分析师，RedHill Biopharma Ltd. 股票共识评级为Buy，12个月平均目标价为 $—。2025 财年 RedHill Biopharma Ltd. 营收 $286000.00，净利润 -$429000.00。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，RedHill Biopharma Ltd.（RDHL）股价为 $1.02，在 NASDAQ 上市，52周区间为 $0.71 – $3.31。

RDHL 最新股价RDHL quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议